Ignite Creation Date:
2025-12-25 @ 3:57 AM
Ignite Modification Date:
2026-01-07 @ 1:34 PM
Study NCT ID:
NCT00099502
Status:
COMPLETED
Last Update Posted:
2008-12-19
First Post:
2004-12-15
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
BEYOND: Betaferon/Betaseron Efficacy Yielding Outcomes of a New Dose in Multiple Sclerosis (MS) Patients
Sponsor:
Bayer
Organization:
Organization Data
Organization:
Class:
INDUSTRY
Study ID:
91162
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
None
Responsible Party Affiliation:
Old Name:
Therapeutic Area Head
Old Organization:
Bayer HealthCare Pharmaceuticals, Inc.